RenoFocus Tabs
High-potency chitosan phosphate binders and alkalinising agents with Co-Enzyme Q10 — for the management of mid to end-stage renal disease in dogs and cats.
Indication
A nutritional aid in dogs and cats in the management of mid to end-stage renal disease. The chitosan binds dietary phosphate while the citrate alkalinises — the two interventions that most reliably change the course of chronic renal disease.
Composition
| Each tablet contains | Amount | |
|---|---|---|
| Calcium carbonate | 500 mg | |
| Potassium citrate | 500 mg | |
| Chitosan | 250 mg | |
| Vitamin C | 150 mg | |
| Vitamin E | 50 mg | |
| Co-Enzyme Q10 | 50 mg | |
| Pyridoxine | 30 mg | |
| Vitamin B12 | 10 mg | |
| Folic acid | 10 mg |
Protocol
By weight
| Bodyweight | Loading, per day | Maintenance, per day | 100 tabs last |
|---|---|---|---|
| 5 kg | 1 tab | 0.5 tab | 200 days |
| 10 kg | 2 tabs | 1 tab | 100 days |
| 20 kg | 4 tabs | 2 tabs | 50 days |
| 40 kg | 8 tabs | 4 tabs | 25 days |
Notes
- Lifelong once started. Maintenance dosing is intended to continue for the rest of the animal’s life.
- Combines with RenoFocus Oil. Tablets carry the binders, the oil carries the omega 3; together they cover both halves.
- Proven to reduce mortality. The nutraceutical combination is the ultimate supportive aid in chronic renal disease.
VetsBrands · quality assured by vets
Available in packs of 100 tablets